New heart pump trial offers hope for shock patients

NCT ID NCT07293923

Recruiting now Disease control Sponsor: Magenta Medical Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 10, 2026 · Updated 17 times

Summary

This study is testing a new temporary heart pump (Magenta Elevate) in 10 people with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The pump is inserted through a blood vessel to help the left ventricle work. The goal is to see if it's safe and can quickly improve blood flow and stability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Israeli-Georgian Medical Research Clinic Helsicore
RECRUITING

Tbilisi, Georgia

Contact
Rambam Medical Center
RECRUITING

Haifa, Israel

Contact
Shamir Medical Center
RECRUITING

Be’er Ya‘aqov, Israel

Contact
Tbilisi Heart Center
RECRUITING

Tbilisi, Georgia

Contact
Tel-Aviv Sourasky Medical Center
RECRUITING

Tel Aviv, Israel

Contact

Conditions

Explore the condition pages connected to this study.

ACUTE MYOCARDIAL INFARCTION (AMI) CARDIOGENIC SHOCK CARDIOGENIC SHOCK HEART FAILURE